Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom
Seye Abogunrin,1 Linda Hortobagyi,2 Edit Remak,3 Jerome Dinet,4 Sylvie Gabriel,5 Abdel Magid O Bakheit6 1Meta Research, 2Health Economics, Evidera, London, UK; 3Health Economics, Evidera, Budapest, Hungary; 4Health Economics and Outcomes Research (Global), 5Global Market Access and Pricing, Ipsen P...
Main Authors: | Abogunrin S, Hortobagyi L, Remak E, Dinet J, Gabriel S, Bakheit AM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-04-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/budget-impact-analysis-of-botulinum-toxin-a-therapy-for-upper-limb-spa-peer-reviewed-article-CEOR |
Similar Items
-
Pharmacoeconomic analysis of botulinum toxins as treatment for treatment of adult upper limb spasticity
by: Dmitry Belousov, et al.
Published: (2019-04-01) -
AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
by: Abogunrin S, et al.
Published: (2015-09-01) -
Botulinum toxin treatment for limb spasticity in childhood cerebral palsy
by: Vito ePavone, et al.
Published: (2016-02-01) -
Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper Limb
by: Tomáš Veverka, et al.
Published: (2019-05-01) -
Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial
by: Nick Steen, et al.
Published: (2012-11-01)